142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

315754
Reproductive, Maternal, Newborn and Child Health on the Post 2015 Development Agenda: Process, goals and strategy

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 4:35 PM - 4:50 PM

Mary Nell Wegner, EdM, MPH , Maternal Health Task Force at the Harvard School of Public Health, Boston, MA
This presentation will describe the current process for development of the post-2015 sustainable development goals; the numerical targets drafted; and the strategies underway to advocate for their inclusion.  While the world has made great strides in some areas of reproductive, maternal, newborn and child health, progress has been uneven.  Some key populations will continue to be disproportionately affected if significant attention and resources are not redirected urgently.  Additionally, while some countries will be able to meet the millennium development goals, others are far from achieving them.  For this reason, the RMNCH community has been using a number of strategies to target specific processes within and outside the United Nations to advocate that the health of women, newborns, and children not fall off the development agenda. This presentation will track where we have been and where we need to go in order to be as strategic as possible about setting RMNCH development goals for post 2015.

Learning Areas:

Advocacy for health and health education

Learning Objectives:
Name one numerical goal stated as a target for the post 2015 development agenda. Describe one advocacy strategy used to support inclusion of a goal in the the post 2015 development agenda

Keyword(s): International MCH, Advocacy

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a global health specialist with over 20 years of experience.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.